The rating downgrade is based on several factors, including BHSF’s marked decline in margins, weaker operations and the presence of multiple competitors in the area.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that reduced operating flexibility will be met with cost and revenue improvement initiatives.
More articles on healthcare finance:
Piedmont receives $75M donation for heart care, capital improvements: 5 things to know
Former hospital executive takes on ‘price gouging’ in healthcare, asks for presidential candidates’ support
eClinicalWorks granted tax break in Mass.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
